Legend Biotech to Host Investor Conference Call on Third Quarter 2025 Results
Legend Biotech (NASDAQ: LEGN) will host a live investor conference call and webcast at 8:00 AM ET on Wednesday, November 12, 2025 to review third quarter 2025 results. Senior leaders will provide an overview of the company’s performance for the quarter.
Investors can join the live audio webcast via the company weblink. A replay of the webcast and the earnings news release will be posted in the Investor Relations site under Events and Presentations approximately two hours after the call concludes.
Legend Biotech (NASDAQ: LEGN) organizzerà una conference call in diretta per gli investitori e una trasmissione web in diretta alle 8:00 AM ET di mercoledì 12 novembre 2025 per rivedere i risultati del terzo trimestre 2025. I dirigenti senior forniranno una panoramica delle prestazioni dell'azienda per il trimestre.
Gli investitori possono partecipare alla trasmissione audio in diretta tramite il link web dell'azienda. Una replica della trasmissione e il comunicato stampa sui risultati saranno pubblicati sul sito Relazioni con gli Investitori nella sezione Eventi e Presentazioni circa due ore dopo la chiusura della call.
Legend Biotech (NASDAQ: LEGN) celebrará una conferencia telefónica en vivo para inversores y una retransmisión web a las 8:00 a. m. hora del Este del miércoles 12 de noviembre de 2025 para revisar los resultados del tercer trimestre de 2025. Los líderes sénior ofrecerán una visión general del desempeño de la empresa durante el trimestre.
Los inversores pueden unirse a la retransmisión en directo a través del enlace web de la empresa. Una repetición de la retransmisión y el comunicado de prensa de resultados se publicarán en el sitio de Relaciones con Inversores bajo Eventos y Presentaciones aproximadamente dos horas después de que termine la llamada.
Legend Biotech (NASDAQ: LEGN)는 2025년 11월 12일 수요일 동부 표준시 8:00 AM에 라이브 투자자 컨퍼런스 콜 및 웹캐스트를 주최하여 2025년 3분기 실적을 검토합니다. 고위 임원진은 분기의 회사 실적에 대한 개요를 제공합니다.
투자자들은 회사 하이퍼링크를 통한 라이브 오디오 웹캐스트에 참여할 수 있습니다. 콜 종료 후 약 두 시간 정도 뒤에 웹캐스트 재생 및 실적 보도자료가 투자자 관계 사이트의 이벤트 및 프레젠테이션 섹션에 게시될 예정입니다.
Legend Biotech (NASDAQ: LEGN) organisera une conférence téléphonique en direct pour les investisseurs et une webdiffusion en direct à 8h00, heure de l'Est, mercredi 12 novembre 2025 afin de passer en revue les résultats du troisième trimestre 2025. Des cadres supérieurs donneront un aperçu de la performance de l'entreprise pour le trimestre.
Les investisseurs peuvent rejoindre la diffusion audio en direct via le lien Web de l'entreprise. Une rediffusion de la diffusion Web et le communiqué de presse sur les résultats seront publiés sur le site des Relations investisseurs dans la section Événements et Présentations environ deux heures après la fin de l'appel.
Legend Biotech (NASDAQ: LEGN) wird am Mittwoch, dem 12. November 2025 um 8:00 Uhr ET eine Live-Investorenkonferenz und einen Webcast abhalten, um die Ergebnisse des dritten Quartals 2025 zu besprechen. Führungskräfte auf Leitungsebene werden einen Überblick über die Performance des Unternehmens im Quartal geben.
Investoren können dem Live-Audio-Webcast über den Unternehmenslink beitreten. Eine Wiederholung des Webcasts und die Gewinnmitteilung werden ca. zwei Stunden nach Ende der Sitzung auf der Investor-Relations-Website unter Veranstaltungen und Präsentationen veröffentlicht.
Legend Biotech (NASDAQ: LEGN) ستستضيف مكالمة هاتفية للمستثمرين وبثاً مباشراً على الويب في الساعة 8:00 صباحاً بتوقيت شرق الولايات المتحدة يوم الأربعاء 12 نوفمبر 2025 لمراجعة نتائج الربع الثالث لعام 2025. سيقدم القادة الكبار لمحة عامة عن أداء الشركة خلال الربع.
يمكن للمستثمرين الانضمام إلى البث الصوتي المباشر عبر رابط الشركة. وسيتم نشر إعادة تشغيل البث وخريطة نتائج الأرباح على موقع علاقات المستثمرين ضمن قسم الأحداث والعروض التقديمية تقريباً بعد مرور حوالي ساعتين من انتهاء المكالمة.
Legend Biotech (NASDAQ: LEGN) 将于 2025年11月12日（星期三）东部时间8:00 举行投资者电话会议和网络直播，回顾2025年第三季度业绩。高级管理人员将提供本季度公司业绩的概览。
投资者可通过公司网页链接参加实时音频网络直播。网络直播重播及收益新闻稿将于电话结束后大约两个小时在投资者关系网站的“事件与演示”栏目中发布。
- None.
- None.
SOMERSET, N.J., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a conference call for investors at 8:00 am ET on Wednesday, November 12, 2025, to review third quarter 2025 results.
During the webcast and conference call, senior leaders will provide an overview of Legend Biotech’s performance for the quarter.
Investors and other interested parties may join the live audio webcast of the call via this weblink.
A replay of the webcast and earnings news release will be available through the Investor Relations section of Legend Biotech’s website under the Events and Presentations section approximately two hours after the call concludes.
ABOUT LEGEND BIOTECH
With over 2,800 employees, Legend Biotech is the largest standalone cell therapy company and a pioneer in treatments that change cancer care forever. The company is at the forefront of the CAR-T cell therapy revolution with CARVYKTI®, a one-time treatment for relapsed or refractory multiple myeloma, which it develops and markets with collaborator Johnson & Johnson. Centered in the US, Legend is building an end-to-end cell therapy company by expanding its leadership to maximize CARVYKTI’s patient access and therapeutic potential. From this platform, the company plans to drive future innovation across its pipeline of cutting-edge cell therapy modalities.
Learn more at www.legendbiotech.com, and follow us on LinkedIn.
INVESTOR CONTACT:
Jessie Yeung
Tel: (732) 956-8271
jessie.yeung@legendbiotech.com
PRESS CONTACT:
Alexandra Ventura
Tel: (732) 850-5598
media@legendbiotech.com
FAQ
When will Legend Biotech (LEGN) discuss Q3 2025 results?
How can I join the Legend Biotech (LEGN) Q3 2025 earnings call webcast?
When will the replay and earnings release for LEGN Q3 2025 be available?
Who will present on Legend Biotech’s Q3 2025 conference call?
Where on Legend Biotech’s site can investors find the Q3 2025 webcast recording?
Is registration required to access the LEGN Q3 2025 webcast on November 12, 2025?
